Enabling point-of-care testing and personalized medicine for schizophrenia
Guardado en:
Autores principales: | Paul C. Guest, Daniel Martins-de-Souza |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/199f9f544ab24d28a18a15b043492b50 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Personalized medicine for schizophrenia
por: Peter F. Buckley, et al.
Publicado: (2017) -
Science of recovery in schizophrenia research: brain and psychological substrates of personalized value
por: Kiyoto Kasai, et al.
Publicado: (2017) -
Historical pursuits of the language pathway hypothesis of schizophrenia
por: Lynn E. DeLisi
Publicado: (2021) -
Schizophrenia genetics comes to translation
por: Enrico Domenici
Publicado: (2017) -
Investigating the effects of genetic risk of schizophrenia on behavioural traits
por: Adam Socrates, et al.
Publicado: (2021)